Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Aesthet Surg J ; 41(11): 1316-1320, 2021 10 15.
Article in English | MEDLINE | ID: mdl-33326584

ABSTRACT

BACKGROUND: The gender pay gap in medicine has been under intense scrutiny in recent years; female plastic surgeons reportedly earn 11% less than their male peers. "Hidden" pay in the form of industry-based transfers exposes compensation disparity not captured by traditional wage-gap estimations. OBJECTIVES: The aim of this study was to reveal the sex distribution of industry payments to board-certified plastic surgeons across all years covered by the Center for Medicare and Medicaid Services Open Payment Database (CMS OPD). METHODS: We obtained the National Provider Identifier (NPI) for each surgeon in the American Society of Plastic Surgeons (ASPS) member directory to record gender. Next, "General Payments" data points from annual files for all years present in the CMS OPD, 2013 to 2018, were aggregated and joined to provider details by Physician Profile ID before quantitative analysis was performed. RESULTS: Of 4840 ASPS surgeons, 3864 (79.8%) reporting ≥1 industry payment were included with 3220 male (83.3%) and 644 female (16.7%). Over 2013 to 2018, females received mean [standard deviation] 56.01 [2.51] payments totaling $11,530.67 [$1461.45] each vs 65.70 [1.80] payments totaling $25,469.05 [$5412.60] for males. The yearly ratio of male-to-female payments in dollars was 2.36 in 2013, 2.69 in 2014, 2.53 in 2015, 2.31 in 2016, 1.72 in 2017, and most recently 1.96 in 2018. CONCLUSIONS: Individual male plastic surgeons received over twice the payment dollars given to their female counterparts, accepting both more frequent and higher-value transfers from industry partners. Payment inequity slightly declined in recent years, which may indicate shifting industry engagement gender preferences.


Subject(s)
Medicare , Surgeons , Aged , Databases, Factual , Female , Humans , Income , Industry , Male , United States
2.
J Invest Dermatol ; 132(12): 2800-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22718114

ABSTRACT

UVB exposure is well known to induce skin photodamage and photoaging that correlates with qualitative and quantitative deterioration of the dermal extracellular matrix (ECM) because of the upregulation of matrix metalloproteinases (MMPs). Although inhibitory effects of tissue inhibitor of metalloproteinases (TIMPs) on most MMPs have been reported, the protective role of TIMP-1 against photodamage is poorly understood. To address this, TIMP-1 function was augmented or abolished in a human skin xenograft photodamage model after the confirmation of significantly diminished TIMP-1 expression both in photoaged and intrinsically aged skins. During a chronic UVB exposure regimen, pre-treatment with a lentiviral vector overexpressing TIMP-1 or concomitant administration of an anti-TIMP-1-neutralizing antibody (NAB) led to photoprotection or more severe photodamage, respectively. Overexpression of TIMP-1 resulted in significant inhibition of UVB-induced ECM degradation, as well as suppression of decreased skin elasticity and roughness, whereas the NAB-mediated inhibition of TIMP-1 had opposite effects. Furthermore, UVB-induced production of the pro-inflammatory cytokine, tumor necrosis factor α, was inhibited by TIMP-1 treatment of human keratinocytes. Taken together, these data shed light on the important role of TIMP-1 in protection and recovery from cutaneous photodamage because of its suppression of ECM degradation and inflammation.


Subject(s)
Skin Aging/pathology , Skin Aging/physiology , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-1/metabolism , Adult , Animals , Antibodies, Neutralizing/pharmacology , Collagen/metabolism , Dermis/pathology , Dermis/physiology , Elastic Tissue/metabolism , Epidermis/pathology , Epidermis/physiology , Female , Gene Expression/physiology , Humans , Lentivirus/genetics , Mice , Mice, Inbred ICR , Mice, SCID , Middle Aged , Skin Transplantation , Tissue Inhibitor of Metalloproteinase-1/immunology , Tissue Inhibitor of Metalloproteinase-2/genetics , Tissue Inhibitor of Metalloproteinase-2/immunology , Tissue Inhibitor of Metalloproteinase-2/metabolism , Tissue Inhibitor of Metalloproteinase-3/genetics , Tissue Inhibitor of Metalloproteinase-3/immunology , Tissue Inhibitor of Metalloproteinase-3/metabolism , Transplantation, Heterologous , Tumor Necrosis Factor-alpha/metabolism , Ultraviolet Rays/adverse effects
3.
J Biomed Mater Res B Appl Biomater ; 97(1): 184-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21328693

ABSTRACT

Wounds often cannot be successfully closed by conventional means of closure such as sutures or staples. Our group developed the FiberSecure™ device to close soft tissue wounds reliably, surpassing native tissue strength. We closed cross-fiber muscle incisions, to evaluate (1) four different configurations of FiberSecure™ for 30 days, then (2) the resulting preferred configuration for 180 days. The four treatment groups each placed 21,504 polyester (PET) 12-µm fibers (cross-sectional area 1% of muscle) traversing the incision, in the form of (A) Four large (No.7 suture) non-textured bundles, (B) Eight small (No.2 suture) non-textured, (C) Four large textured, or (D) Eight small textured. Four incisions were closed in the external oblique muscle of 16 Sinclair minipigs. At 30 days, specimens were removed for biomechanics, histology, and total collagen content. Group (B) was selected for 180-day evaluations in the same wound model in eight animals, four closures each (n = 32), again with biomechanics and histology. In strength testing, every specimen tore through muscle remotely, while the repair region remained intact. Maximum forces were (A) 37.8 ± 3.9 N, (B) 37.1 ± 4.7 N, (C) 39.0 ± 5.3 N, and (D) 32.4 ± 3.4 N at 30 days, and 37.2 ± 11.3 N at 180 days (mean ± SEM). No significant difference was observed among the groups or time points (p > 0.05).


Subject(s)
Bandages , Materials Testing/methods , Muscle, Skeletal/injuries , Wounds, Penetrating/therapy , Animals , Female , Muscle, Skeletal/pathology , Swine , Swine, Miniature , Time Factors , Wounds, Penetrating/pathology
4.
J Invest Dermatol ; 131(2): 320-8, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20944648

ABSTRACT

The hair follicle has a unique dynamic property to cyclically regenerate throughout life. Despite significant progress in hair structure and hair shape determination using animal models, the mechanisms controlling the architecture and the shape of the human hair remain largely unexplored. In this study, comparison of the genetic expression of several human genes, especially those involved in growth, development, and differentiation, between Caucasian curly hair and naturally straight hair was performed. Thereafter, analyses using human recombinant and lentiviral vector technologies were conducted to further dissect and elucidate a molecular mechanism that regulates hair growth and development, particularly in controlling the shape of the hair shaft. Overexpression of IGF-binding protein 5 (IGFBP-5) in the human hair xenografts obtained from straight- and curly-haired individuals was found to result in the decreased expression of several extracellular matrix proteins and disassembly of adhesional junctions, resulting in twisted hair shafts as well as an unusual deposition of hair cuticle that may be derived from the disturbance of normal proliferation and differentiation. This study provides evidence that IGFBP-5 has an effect on human hair shape, and that lentiviral transduction regimen can be used for functional analysis of genes involved in human hair morphogenesis.


Subject(s)
Hair/anatomy & histology , Hair/physiology , Insulin-Like Growth Factor Binding Protein 5/physiology , Morphogenesis/physiology , Phenotype , Actins/metabolism , Adult , Animals , Cell Differentiation/physiology , Cell Proliferation , Cells, Cultured , Dermis/cytology , Dermis/drug effects , Dermis/metabolism , Extracellular Matrix Proteins/metabolism , Hair/growth & development , Hair Follicle/cytology , Hair Follicle/drug effects , Hair Follicle/metabolism , Humans , Insulin-Like Growth Factor Binding Protein 5/genetics , Insulin-Like Growth Factor Binding Protein 5/pharmacology , Keratinocytes/cytology , Keratinocytes/drug effects , Keratinocytes/metabolism , Lentivirus/genetics , Male , Mice , Mice, SCID , Transfection , Transplantation, Heterologous
5.
Sci Rep ; 1: 164, 2011.
Article in English | MEDLINE | ID: mdl-22355679

ABSTRACT

UVB-induced cutaneous photodamage/photoaging is characterized by qualitative and quantitative deterioration in dermal extracellular matrix (ECM) components such as collagen and elastic fibers. Disappearance of microfibrillar-associated protein 4 (MFAP-4), a possible limiting factor for cutaneous elasticity, was documented in photoaged dermis, but its function is poorly understood. To characterize its possible contribution to photoprotection, MFAP-4 expression was either augmented or inhibited in a human skin xenograft photodamage murine model and human fibroblasts. Xenografted skin with enhanced MFAP-4 expression was protected from UVB-induced photodamage/photoaging accompanied by the prevention of ECM degradation and aggravated elasticity. Additionally, remarkably increased or decreased fibrillin-1-based microfibril development was observed when fibroblasts were treated with recombinant MFAP-4 or with MFAP-4-specific siRNA, respectively. Immunoprecipitation analysis confirmed direct interaction between MFAP-4 and fibrillin-1. Taken together, our findings reveal the essential role of MFAP-4 in photoprotection and offer new therapeutic opportunities to prevent skin-associated pathologies.


Subject(s)
Carrier Proteins/metabolism , Extracellular Matrix Proteins/metabolism , Glycoproteins/metabolism , Skin/metabolism , Animals , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Carrier Proteins/pharmacology , Elasticity , Extracellular Matrix Proteins/antagonists & inhibitors , Extracellular Matrix Proteins/genetics , Extracellular Matrix Proteins/pharmacology , Fibrillin-1 , Fibrillins , Glycoproteins/antagonists & inhibitors , Glycoproteins/genetics , Glycoproteins/pharmacology , Homeostasis , Humans , Mice , Microfilament Proteins/metabolism , RNA, Small Interfering/genetics , Recombinant Proteins/pharmacology , Skin/drug effects , Skin/radiation effects , Skin Aging/physiology , Skin Physiological Phenomena , Transplantation, Heterologous , Ultraviolet Rays/adverse effects
7.
Am J Pathol ; 174(2): 401-13, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19147832

ABSTRACT

UVB irradiation has been reported to induce photoaging and suppress systemic immune function that could lead to photocarcinogenesis. However, because of the paucity of an UVB-induced photodamaged skin model, precise and temporal mechanism(s) underlying the deleterious effects of long-term UVB exposure on human skin have yet to be delineated. In this study, we established a model using human skin xenografted onto severe combined immunodeficient mice, which were subsequently challenged by repeated UVB irradiation for 6 weeks. Three-dimensional optical image analysis of skin replicas and noninvasive biophysical measurements illustrated a significant increase in skin surface roughness, similar to premature photoaging, and a significant loss of skin elasticity after long-term UVB exposure. Resembling authentically aged skin, UVB-exposed samples exhibited significant increases in epithelial keratins (K6, K16, K17), elastins, and matrix metalloproteinases (MMP-1, MMP-9, MMP-12) as well as degradation of collagens (I, IV, VII). The UVB-induced deterioration of fibrous keratin intermediate filaments was also observed in the stratum corneum. Additionally, similarities in gene expression patterns between our model and chronologically aged skin substantiated the plausible relationship between photodamage and chronological age. Furthermore, severe skin photodamage was observed when neutralizing antibodies against TIMP-1, an endogenous inhibitor of MMPs, were administered during the UVB exposure regimen. Taken together, these findings suggest that our skin xenograft model recapitulates premature photoaged skin and provides a comprehensive tool with which to assess the deleterious effects of UVB irradiation.


Subject(s)
Dermis/radiation effects , Epidermis/radiation effects , Skin Aging/radiation effects , Ultraviolet Rays/adverse effects , Adult , Animals , Blotting, Western , Collagen/metabolism , Collagen/radiation effects , Dermis/pathology , Disease Models, Animal , Elasticity/radiation effects , Elastin/metabolism , Elastin/radiation effects , Epidermis/pathology , Female , Gene Expression Profiling , Humans , Immunohistochemistry , Keratins/metabolism , Keratins/radiation effects , Matrix Metalloproteinases/metabolism , Matrix Metalloproteinases/radiation effects , Mice , Mice, SCID , Microscopy, Electron, Transmission , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Tissue Inhibitor of Metalloproteinase-1/antagonists & inhibitors , Transplantation, Heterologous
SELECTION OF CITATIONS
SEARCH DETAIL
...